ENTA ENANTA PHARMACEUTICALS INC: institutional ownership and insider trading
131 funds reported holding $483M of ENANTA PHARMACEUTICALS INC in their latest 13F filings; in Q2 2026 funds net bought $9.32M, with 10 new positions and 19 funds selling out; over the last 12 months insiders bought $0 and sold $183K on the open market; over its last four quarters it reported revenue of $65.3M and net income of −$63.2M.
ENTA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $14.4M, net income −$19.5M, EPS -0.67
- Quarter ended Mar 31, 2026: revenue $17.2M, net income −$13.1M, EPS -0.45
- Quarter ended Dec 31, 2025: revenue $18.6M, net income −$11.9M, EPS -0.42
- Quarter ended Sep 30, 2025: revenue $15.1M, net income −$18.7M, EPS -0.88
Famous investors holding ENTA
- Renaissance Technologies (Renaissance Technologies): $8.13M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $9.39M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.12M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.04M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $504K, 0.0% of the portfolio
Largest institutional holders of ENTA
- Jupiter Topco LLC — $53.3M
- JANUS HENDERSON GROUP PLC (JHG) — $47.7M
- BlackRock, Inc. (BLK) — $47.3M
- Krensavage Asset Management, LLC — $41.8M
- VANGUARD GROUP INC — $36.3M
- FARALLON CAPITAL MANAGEMENT, L.L.C. — $35.3M
- Deep Track Capital, LP — $21.1M
- ADAR1 Capital Management, LLC — $19.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $17.7M
- Spruce Street Capital LP — $15.9M
Recent ENTA insider trades
- Dec 5, 2025: Luly Jay R. sold 4,743 shares ($67.5K)
- Dec 5, 2025: Or Yat Sun sold 2,390 shares ($34.0K)
- Dec 5, 2025: Kieffer Tara Lynn sold 2,106 shares ($30.0K)
- Dec 5, 2025: Luu Brendan sold 1,394 shares ($19.8K)
5%+ owners
- Farallon Capital Management, L.L.C.: 8.3% (Schedule 13G/A, filed Aug 14, 2026)